Corbus Pharmaceuticals Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $168.2M
Liabilities Breakdown FY2025
Total Liabilities: $20.7M
Asset Breakdown
Total Assets: $168.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $28.5M | 16.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $159.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $139.5M | 83.0% |
Liabilities Breakdown
Total Liabilities: $20.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 10.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.5M | 89.3% |